
|Articles|January 6, 2005
Prescription drug for premature ejaculation moves closer to approval
The FDA has received a new drug application from ALZA Corp. for dapoxetine hydrochloride, a possible new treatment for premature ejaculation.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Study suggests potential diuretic effect with nadofaragene firadenovec
2
The UroOnc Minute: MDT for Oligometastatic Prostate Cancer, with Chad Tang, MD
3
Praful Ravi, MB, BChir, MRCP, on PSMA-PET during initial systemic therapy for mHSPC
4
Published data show DFS benefit with aglatimagene besadenovec in localized prostate cancer
5











